Clinical Trial

Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

Name: Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients — clinical trial record (NCT07598214)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Dios/Hes-PT

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The current study aims to investigate the protective properties of diosmin/hesperidin on cisplatin-induced nephrotoxicity.

Trial Details

NCT Number	NCT07598214
Lead Sponsor	Beni-Suef University
Conditions	Cancer Patients
Enrollment	100 participants
Start Date	2025-02-03
Primary Completion	2026-11-03 (estimated)
Study Completion	2026-12-03 (estimated)
Updated on ClinicalTrials.gov	2026-05-20